Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Mar;22(3):404-9.
doi: 10.3201/eid2203.151265.

Methylotroph Infections and Chronic Granulomatous Disease

Case Reports

Methylotroph Infections and Chronic Granulomatous Disease

E Liana Falcone et al. Emerg Infect Dis. 2016 Mar.

Abstract

Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by a defect in production of phagocyte-derived reactive oxygen species, which leads to recurrent infections with a characteristic group of pathogens not previously known to include methylotrophs. Methylotrophs are versatile environmental bacteria that can use single-carbon organic compounds as their sole source of energy; they rarely cause disease in immunocompetent persons. We have identified 12 infections with methylotrophs (5 reported here, 7 previously reported) in patients with CGD. Methylotrophs identified were Granulibacter bethesdensis (9 cases), Acidomonas methanolica (2 cases), and Methylobacterium lusitanum (1 case). Two patients in Europe died; the other 10, from North and Central America, recovered after prolonged courses of antimicrobial drug therapy and, for some, surgery. Methylotrophs are emerging as disease-causing organisms in patients with CGD. For all patients, sequencing of the 16S rRNA gene was required for correct diagnosis. Geographic origin of the methylotroph strain may affect clinical management and prognosis.

Keywords: Acidomonas methanolica; Granulibacter bethesdensis; Methylobacterium lusitanum; bacteria; chronic granulomatous disease; methylotroph.

PubMed Disclaimer

References

    1. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170–200 . 10.1097/00005792-200005000-00004 - DOI - PubMed
    1. Matute JD, Arias AA, Wright NA, Wrobel I, Waterhouse CC, Li XJ, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009;114:3309–15. 10.1182/blood-2009-07-231498 - DOI - PMC - PubMed
    1. Anthony C. The biochemistry of methylotrophs. New York, Academic Press; 1982. p. 2–3.
    1. Chase JM, Holland SM, Greenberg DE, Marshall-Batty K, Zelazny AM, Church JA. Acidomonas methanolica–associated necrotizing lymphadenitis in a patient with chronic granulomatous disease. J Clin Immunol. 2012;32:1193–6. 10.1007/s10875-012-9728-6 - DOI - PMC - PubMed
    1. López FC, de Luna FF, Delgado MC, de la Rosa II, Valdezate S, Nieto JA, et al. Granulibacter bethesdensis isolated in a child patient with chronic granulomatous disease. J Infect. 2008;57:275–7. 10.1016/j.jinf.2008.04.011 - DOI - PubMed

Publication types

LinkOut - more resources